Zotefoams PLC
16 April 2002
PRESS ANNOUNCEMENT
FOR IMMEDIATE RELEASE
16 April 2002
Zotefoams plc
('Zotefoams' or 'the Company')
Disclosure of shareholding interest in Zotefoams
Zotefoams was notified today that earlier this afternoon, Alveo AG ('Alveo'), a
subsidiary of Sekisui Chemical Co. Limited ('Sekisui'), acquired 2,797,200
ordinary shares in Zotefoams, representing 7.72 per cent. of Zotefoams' issued
ordinary share capital. No shares were held prior to this acquisition.
These shares will be registered in the name of Alveo.
Commenting on the above, Dr Bill Fairservice, Chairman of Zotefoams said:
'Sekisui is a valued strategic partner of Zotefoams and we welcome its
acquisition of a shareholding in the Company. We look forward to continuing to
develop our commercial relationship with Sekisui for the benefit of all
Zotefoams shareholders'.
Mr Gen Endo, President of High Performance Plastics Company of Sekisui, added:
'Sekisui is pleased to cement its trading ties with Zotefoams by taking a small
but significant shareholding. Our strategic alliance has already achieved
success in Europe and we expect to mirror this in North America, Asia and Latin
America'.
Enquiries:
Financial Dynamics Limited Tel: 020 7269 7182
Charlie Armitstead
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.